PHENOMEX INC (CELL) Stock Price & Overview
NASDAQ:CELL • US0843101017
Current stock price
The current stock price of CELL is 0.9981 USD. Today CELL is up by 0.31%. In the past month the price increased by 5.06%.
CELL Key Statistics
- Market Cap
- 98.792M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.38
- Dividend Yield
- N/A
CELL Stock Performance
CELL Stock Chart
CELL Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to CELL.
CELL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CELL. CELL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CELL Earnings
CELL Forecast & Estimates
11 analysts have analysed CELL and the average price target is 1.53 USD. This implies a price increase of 53.29% is expected in the next year compared to the current price of 0.9981.
For the next year, analysts expect an EPS growth of 17.97% and a revenue growth -10.41% for CELL
CELL Groups
Sector & Classification
CELL Financial Highlights
Over the last trailing twelve months CELL reported a non-GAAP Earnings per Share(EPS) of -1.38. The EPS decreased by -9.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -69.85% | ||
| ROE | -111.9% | ||
| Debt/Equity | 0 |
CELL Ownership
CELL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.82 | 178.329B | ||
| DHR | DANAHER CORP | 22.33 | 130.036B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 130.61 | 41.932B | ||
| A | AGILENT TECHNOLOGIES INC | 17.04 | 31.654B | ||
| WAT | WATERS CORP | 20.49 | 28.78B | ||
| IQV | IQVIA HOLDINGS INC | 13.31 | 27.893B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.89 | 25.37B | ||
| ILMN | ILLUMINA INC | 23.56 | 18.472B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 30.94 | 17.67B | ||
| MEDP | MEDPACE HOLDINGS INC | 27.55 | 13.063B | ||
| RVTY | REVVITY INC | 15.89 | 9.478B | ||
| TECH | BIO-TECHNE CORP | 23.49 | 8.142B | ||
| CRL | CHARLES RIVER LABORATORIES | 15.47 | 7.863B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CELL
Company Profile
PhenomeX, Inc. is a biology company that engages in the study of cells. The company is headquartered in Emeryville, California and currently employs 285 full-time employees. The company went IPO on 2020-07-17. The firm enables scientists to leverage each cell and drive the next generation of functional cell biology that will advance human health. The firm enables scientists to reveal insights into cell function and obtain a full view of the behavior of each cell. Its specific suite of proven tools and services offers unparalleled resolution and speed the insights that are key to advancing discoveries that can completely improve the prevention and treatment of disease. The Company’s platforms are used by researchers across the globe, including various global pharmaceutical companies and approximately 85% of United States cancer centers.
Company Info
IPO: 2020-07-17
PHENOMEX INC
5858 Horton Street, Suite 320
Emeryville CALIFORNIA US
Employees: 285
Phone: 15108582855.0
PHENOMEX INC / CELL FAQ
What does PHENOMEX INC do?
PhenomeX, Inc. is a biology company that engages in the study of cells. The company is headquartered in Emeryville, California and currently employs 285 full-time employees. The company went IPO on 2020-07-17. The firm enables scientists to leverage each cell and drive the next generation of functional cell biology that will advance human health. The firm enables scientists to reveal insights into cell function and obtain a full view of the behavior of each cell. Its specific suite of proven tools and services offers unparalleled resolution and speed the insights that are key to advancing discoveries that can completely improve the prevention and treatment of disease. The Company’s platforms are used by researchers across the globe, including various global pharmaceutical companies and approximately 85% of United States cancer centers.
What is the current price of CELL stock?
The current stock price of CELL is 0.9981 USD. The price increased by 0.31% in the last trading session.
Does PHENOMEX INC pay dividends?
CELL does not pay a dividend.
How is the ChartMill rating for PHENOMEX INC?
CELL has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Would investing in PHENOMEX INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CELL.
What is the employee count for CELL stock?
PHENOMEX INC (CELL) currently has 285 employees.
What is the ownership structure of PHENOMEX INC (CELL)?
You can find the ownership structure of PHENOMEX INC (CELL) on the Ownership tab.